Biotechnology ResearchCalifornia, United States201-500 Employees
Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases. Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents.
| Nurix Therapeutics Email Formats | Percentage |
| FLast@nurixtx.com | 78% |
| Last@nurixtx.com | 18% |
| First.Last@nurixtx.com | 4% |
| FLast@nurix-inc.com | 88% |
| Last@nurix-inc.com | 8% |
| First@nurix-inc.com | 1% |
| FMiddleLast@nurix-inc.com | 1% |
| F.Last@nurix-inc.com | 1% |
| LastF@nurix-inc.com | 1% |
Check if your email matches the formats in our database with our efficient email format checker tool.
| Matching Format | Percentage |
| FLast@nurixtx.com | 78% |
| Last@nurixtx.com | 18% |
| First.Last@nurixtx.com | 4% |
| FLast@nurix-inc.com | 88% |
| Last@nurix-inc.com | 8% |
| First@nurix-inc.com | 1% |
| FMiddleLast@nurix-inc.com | 1% |
| F.Last@nurix-inc.com | 1% |
| LastF@nurix-inc.com | 1% |
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com